Literature DB >> 18176767

Cetuximab-induced acneiform eruption and the response to isotretinoin.

Pamela Vezzoli, Angelo Valerio Marzano, Franceso Onida, Elvio Alessi, Barbara Galassi, Maurizio Tomirotti, Emilio Berti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18176767     DOI： 10.2340/00015555-0330

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  4 in total

1.  Clinical response of acneiform eruptions caused by cetuximab to administration of oral tetracycline and topical ketoconazole.

Authors:  Satoshi Nakamura; Yoshio Hashimoto; Kaoru Nishi; Tosihiro Mizumoto; Hidetoshi Takahashi; Hajime Iizuka
Journal:  J Dermatol Case Rep       Date:  2014-03-31

Review 2.  Skin problems and EGFR-tyrosine kinase inhibitor.

Authors:  Toshiyuki Kozuki
Journal:  Jpn J Clin Oncol       Date:  2016-01-29       Impact factor: 3.019

Review 3.  Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Authors:  Mario E Lacouture; Milan J Anadkat; René-Jean Bensadoun; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2011-06-01       Impact factor: 3.603

4.  Genetic Predictors of Severe Skin Toxicity in Patients with Stage III Colon Cancer Treated with Cetuximab: NCCTG N0147 (Alliance).

Authors:  Julia D Labadie; Xinwei Hua; Tabitha A Harrison; Barbara L Banbury; Jeroen R Huyghe; Wei Sun; Qian Shi; Greg Yothers; Steven R Alberts; Frank A Sinicrope; Richard M Goldberg; Thomas J George; Kathryn L Penney; Amanda I Phipps; Stacey A Cohen; Ulrike Peters; Andrew T Chan; Polly A Newcomb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-11-17       Impact factor: 4.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.